Cbl-b and itch: Key regulators of peripheral T-cell tolerance

Research output: Contribution to journalReview article

24 Citations (Scopus)

Abstract

E3 ligases Cbl-b and Itch have emerged as dominant "tolerogenic" regulators of T cells because their deficiency results in severe autoimmune diseases. Cbl-b and Itch ligase activity regulate T-cell anergy and development of Foxp3+ regulatory T cells (Treg) in the periphery by modulating key components of T-cell receptor (TCR) and transforming growth factor-β (TGF-β) signaling. Manipulation of Cbl-b and Itch activities may provide unique opportunities to develop future therapies for immune disorders such as autoimmunity and cancer.

Original languageEnglish (US)
Pages (from-to)3009-3012
Number of pages4
JournalCancer Research
Volume70
Issue number8
DOIs
StatePublished - Apr 15 2010
Externally publishedYes

Fingerprint

T-Lymphocytes
Ubiquitin-Protein Ligases
Immune System Diseases
Transforming Growth Factors
Regulatory T-Lymphocytes
Ligases
T-Cell Antigen Receptor
Autoimmunity
Autoimmune Diseases
Interleukin-2
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Cbl-b and itch : Key regulators of peripheral T-cell tolerance. / Venuprasad, K. Poojary.

In: Cancer Research, Vol. 70, No. 8, 15.04.2010, p. 3009-3012.

Research output: Contribution to journalReview article

@article{4e24d5ba901441329cb140cc90fd9b3b,
title = "Cbl-b and itch: Key regulators of peripheral T-cell tolerance",
abstract = "E3 ligases Cbl-b and Itch have emerged as dominant {"}tolerogenic{"} regulators of T cells because their deficiency results in severe autoimmune diseases. Cbl-b and Itch ligase activity regulate T-cell anergy and development of Foxp3+ regulatory T cells (Treg) in the periphery by modulating key components of T-cell receptor (TCR) and transforming growth factor-β (TGF-β) signaling. Manipulation of Cbl-b and Itch activities may provide unique opportunities to develop future therapies for immune disorders such as autoimmunity and cancer.",
author = "Venuprasad, {K. Poojary}",
year = "2010",
month = "4",
day = "15",
doi = "10.1158/0008-5472.CAN-09-4076",
language = "English (US)",
volume = "70",
pages = "3009--3012",
journal = "Cancer Research",
issn = "0008-5472",
number = "8",

}

TY - JOUR

T1 - Cbl-b and itch

T2 - Key regulators of peripheral T-cell tolerance

AU - Venuprasad, K. Poojary

PY - 2010/4/15

Y1 - 2010/4/15

N2 - E3 ligases Cbl-b and Itch have emerged as dominant "tolerogenic" regulators of T cells because their deficiency results in severe autoimmune diseases. Cbl-b and Itch ligase activity regulate T-cell anergy and development of Foxp3+ regulatory T cells (Treg) in the periphery by modulating key components of T-cell receptor (TCR) and transforming growth factor-β (TGF-β) signaling. Manipulation of Cbl-b and Itch activities may provide unique opportunities to develop future therapies for immune disorders such as autoimmunity and cancer.

AB - E3 ligases Cbl-b and Itch have emerged as dominant "tolerogenic" regulators of T cells because their deficiency results in severe autoimmune diseases. Cbl-b and Itch ligase activity regulate T-cell anergy and development of Foxp3+ regulatory T cells (Treg) in the periphery by modulating key components of T-cell receptor (TCR) and transforming growth factor-β (TGF-β) signaling. Manipulation of Cbl-b and Itch activities may provide unique opportunities to develop future therapies for immune disorders such as autoimmunity and cancer.

UR - http://www.scopus.com/inward/record.url?scp=77951034912&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951034912&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-09-4076

DO - 10.1158/0008-5472.CAN-09-4076

M3 - Review article

C2 - 20395198

AN - SCOPUS:77951034912

VL - 70

SP - 3009

EP - 3012

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 8

ER -